Mains Answer Writing - 13 Jan, 2026

GS3

Science & Technology

15 marks

“Recent advances in CRISPR technology have enabled the reactivation of silenced genes without cutting DNA by targeting epigenetic markers.”
In this context, explain the role of epigenetic gene silencing in human diseases and critically examine how non–DNA-cutting CRISPR approaches could make gene therapy safer and more ethical, with special reference to sickle cell disease.

Tips for your answer

  • Start with concepts: Briefly define epigenetics and gene silencing (methylation as chemical tags).
  • Link innovation to application: Explain how non-cutting CRISPR reactivates the foetal haemoglobin gene in sickle cell disease.
  • Critically evaluate: Compare with conventional CRISPR—highlight safety, reduced off-target effects, and ethical advantages.

More Challenges

View All
  • GS2

    International Relations

    14 Aug, 2026

    Power trade is emerging as an important instrument of India’s neighbourhood diplomacy. Examine how electricity cooperation with Bangladesh, Nepal and Bhutan can advance India’s strategic and economic interests while promoting regional integration.

    View Challenge
  • GS2

    Indian Polity

    Yesterday

    The FCRA Amendment Bill, 2026 seeks to strengthen state oversight over foreign-funded organisations while raising concerns about civil society autonomy. Critically examine.

    View Challenge
  • GS3

    Economy

    12 Aug, 2026

    The next phase of India's MSME growth lies not merely in creating more enterprises, but in clustering them. Examine how a cluster-based approach can enhance the productivity and global competitiveness of Indian MSMEs.

    View Challenge

Master Answer Writingfor UPSC Mains

Join thousands of aspirants mastering answer writing with daily challenges, instant AI evaluation, and topper copies

View Today's Challenge
SuperKalam
SuperKalam is your personal mentor for UPSC preparation, guiding you at every step of the exam journey.

Download the App

Get it on Google PlayDownload on the App Store
Follow us

ⓒ Snapstack Technologies Private Limited